Kansas City, MO (PRWEB) February 14, 2011
Viracor-IBT Laboratories today announced the appointment of Paul R. Sohmer, M.D. as its President and Chief Executive Officer.
“We are, indeed, most fortunate to have Paul Sohmer join us,” said Laurence McCarthy, chairman of the Viracor-IBT board of directors. “He is a proven leader with a track record of success who has consistently explored and implemented new and creative approaches to solve problems in medical diagnosis.”
Dr. Sohmer has served as CEO of both public and privately held growth companies focused on laboratory services, medical devices, and biotechnology including TriPath Imaging, Inc., Neuromedical Systems, Inc., Genetrix, Inc., the Pathology Institute, Inc. and, most recently, Orthocon, Inc. During his tenure with the Pathology Institute, he led the first commercial introduction of polymerase chain reaction (PCR) for diagnosis and founded the Chiron Reference Laboratory. Within laboratory services, Dr. Sohmer brings a broad range of leadership experience including hospital-based, esoteric reference, and national reference laboratory oversight and direction. A graduate of Northwestern University and the Chicago Medical School,
Dr. Sohmer was named the Ernst and Young Carolinas Life Sciences Entrepreneur of the Year® in 2005. Viracor-IBT Laboratories is a specialty diagnostics laboratory focused on immunology, infectious disease and allergy testing. Created by the merger of Viracor Laboratories and IBT Laboratories in 2009, the company provides a wide range of clinical laboratory and biopharmaceutical services to over 4,000 health care providers, commercial laboratories, and biopharmaceutical companies throughout the United States.
“I am thrilled to have the opportunity to be part of the Viracor-IBT team,” said Dr. Sohmer. “The company’s commitment to quality, excellence and innovation in both science and service is well recognized and provides a strong foundation from which to create a very exciting future.”
About Viracor-IBT Laboratories
Viracor-IBT is redefining patient care through innovative molecular and immuno-diagnostics. With a menu of more than 2,000 tests and a dedication to excellence in science and client service, the company offers an unparalleled array of immunology, infectious disease, and allergy testing with the fastest turnaround time in the industry. Viracor-IBT serves physicians, hospitals, commercial laboratories, and biopharmaceutical companies throughout the United States. For more information, visit http://www.ViracorIBT.com.